Author

Kaija Strautins

Observed names: K Strautins, K. Strautins, Strautins, K., Strautins, Kaija

Institution: Government of Western Australia Department of Health

Observed institutions: Murdoch University, Government of Western Australia Department of Health

OpenAlex ID: A5050893271

The Combined Utility of Ex Vivo IFN-γ Release Enzyme-Linked ImmunoSpot Assay and In Vivo Skin Testing in Patients with Antibiotic-Associated Severe Cutaneous Adverse Reactions

2017 · Jason A. Trubiano, Kaija Strautins, et al. · The Journal of Allergy and Clinical Immunology In Practice · 69

New genetic predictors for abacavir tolerance in HLA-B*57:01 positive individuals

2020 · Rebecca Pavlos, Pooja Deshpande, et al. · Human Immunology · 27

Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis

2016 · Monika Tschochner, Shay Leary, et al. · PLoS ONE · 22

PDF

Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis

2016 · Jason A. Trubiano, Alec Redwood, et al. · The Journal of Allergy and Clinical Immunology In Practice · 17

Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk

2013 · K Strautins, M Tschochner, et al. · Multiple Sclerosis Journal · 15

7th drug hypersensitivity meeting: part one

2016 · NASA Study Group, Daniel F. Carr, et al. · Clinical and Translational Allergy · 9

PDF

Post-licensure safety monitoring of nirsevimab in Western Australia 2024

2026 · Kaija Strautins, Rachel Foong, et al. · Vaccine · 1

7th Drug hypersensitivity meeting: part two

2016 · Javier Dionicio Elera, Cosmin Boteanu, et al. · Clinical and Translational Allergy · 1

PDF

P25: THE COMBINED UTILITY OF EX VIVO IFN‐γ RELEASE ENZYME LINKED IMMUNOSPOT AND IN VIVO SKIN TESTING IN PATIENTS WITH ANTIBIOTIC ASSOCIATED SEVERE CUTANEOUS ADVERSE DRUG REACTIONS

2017 · JA Trubiano, K Strautins, et al. · Internal Medicine Journal

PDF

Variation in EraP Influencees Risk for HLA-B*57:01 positive abacavir hypersensitivity

2016 · Rebecca Pavlos, K. Strautins, et al. · Murdoch University Research Portal

PDF

Contribution of EBV infection to Multiple Sclerosis Pathogenesis: Human leukocyte antigen restricted, EBV epitope-specific T cell responses in Multiple Sclerosis

2016 · M. Tschochner, K. Strautins, et al. · Murdoch University Research Portal

PDF

Single cell analysis of drug responsive T cells; identification of candidate drug reactive T cell receptors in abacavir and carbamazepine hypersensitivity

2016 · Alec Redwood, Katie D. White, et al. · Murdoch University Research Portal

PDF

Enzyme linked Immunospot assay used in the diagnosis of severe cutaneous adverse reactions to antimicrobials

2016 · Alec Redwood, J.A. Trubiano, et al. · Murdoch University Research Portal

Identifying novel potential cross-reactive targets in Multiple Sclerosis

2016 · K. Strautins, M. Tschochner, et al. · Murdoch University Research Portal

PDF

Investigating the role of Epstein-Barr virus in the pathogenesis of Multiple Sclerosis

2015 · K. Strautins · Murdoch University Research Portal

Investigating the role of EBV infection in multiple sclerosis pathogenesis

2015 · K. Strautins, M. Tschochner, et al. · Murdoch University Research Portal

PDF

Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risks

2014 · K. Strautins, M. Tschochner, et al. · Murdoch University Research Portal

Adaptive immune responses against Epstein-Barr Virus influencing Multiple Sclerosis risk

2014 · K. Strautins · Murdoch University Research Portal

Multiple Sclerosis Patient Sequence Variation In Epstein-Barr Virus Nuclear Antigen 1

2013 · M. Tschochner, Shay Leary, et al. · Murdoch University Research Portal

PDF

Identifying Epstein-Barr virus EBNA-1 sequence variation using 454 FLX technology in Multiple Sclerosis patient samples

2013 · M. Tschochner, Shay Leary, et al. · Murdoch University Research Portal

PDF

Combining genetic risk factors, gender And Anti-Epstein Barr Virus (EBV) antibody profiles, sing A Novel Anti-EBV Nuclear Antigen-1 (EBNA-1) B Cell Epitope ELISA, to stratify multiple sclerosis risk

2013 · K. Strautins, M. Tschochner, et al. · Murdoch University Research Portal

PDF

Influence of gender, genetic factors and Epstein-Barr Virus antibody profiles, on Multiple Sclerosis risk

2013 · K. Strautins, M. Tschochner, et al. · Murdoch University Research Portal

Epstein-Barr virus (EBV) - specific antibodies in multiple sclerosis patients, including targeted investigation of a candidate EBV nuclear antigen-1 (EBNA-1) B cell epitope

2012 · K. Strautins, M. Tschochner, et al. · Murdoch University Research Portal

PDF

Development of an anti-Epstein-Barr Virus nuclear antigen-1 ELISA and investigation of B-cell-epitope specific antibodies in Multiple Sclerosis patients

2012 · K. Strautins, M. Tschochner, et al. · Murdoch University Research Portal

Investigating Epstein-Barr virus (EBV) antibodies in Multiple Sclerosis patients, and development of an anti-EBV nuclear antigen-1 B cell epitope ELISA

2012 · K. Strautins, M. Tschochner, et al. · Murdoch University Research Portal

Works count: 28

Citation count: 161

H-index: 6

I10-index: 5